Comparing Outcome of Thoracocentesis and Pigtail Catheter Drainage in Treatment of Patients With Hepatic Hydrothorax
- Conditions
- Hepatic Hydrothorax
- Interventions
- Procedure: Thoracocentasis
- Registration Number
- NCT06319547
- Lead Sponsor
- Sohag University
- Brief Summary
Hepatic hydrothorax (HH) is a pleural effusion that develops in a patient with cirrhosis and portal hypertension in the absence of cardiopulmonary disease (Lv et al., 2018). Several factors are known to contribute to the development of effusion; the most accepted mechanism of which is the direct delivery of ascitic fluid from the peritoneal cavity to the pleural cavity by "positive" intra-abdominal pressure and a "negative" intrathoracic pressure of the pleural cavity through microscopic congenital diaphragmatic defects (Han et al., 2022).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Patients who met the following inclusion criteria were enrolled:
- Liver cirrhosis (with or without hepatocellular carcinoma).
- Hepatic hydrothorax (bilateral or unilateral).
- patients with a pleural effusion due to a condition other than HH.
- who had a diagnosis of tuberculosis pleurisy, parapneumonic effusion, inflammatory pleuritis, other neoplasms, and congestive heart failure.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description hepatic hydrothorax Thoracocentasis patient with hepatic hydrothorax that develop pleural effusion either unilateral or bilateral
- Primary Outcome Measures
Name Time Method percentage of empyema in patients with hepatic hydrothorax after thoracocentesis 12 months Patients with hepatic hydrothorax that undergo repeated thoracocentesis will be monitored for presence of any side effects as empyema
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag University hospitals
🇪🇬Sohag, Egypt